Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-17

Clinical Trial Update: Enteral Levetiracetam For Seizure Control In Pediatric Cerebral Malaria [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating enteral levetiracetam for seizure control in pediatric cerebral malaria has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: University of Rochester | Conditions: Seizure, Epilepsy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-10-17